PTCH2
protein-codingpatched 2
Gene summary
This gene encodes a transmembrane receptor of the patched gene family. The encoded protein may function as a tumor suppressor in the hedgehog signaling pathway. Alterations in this gene have been associated with nevoid basal cell carcinoma syndrome, basal cell carcinoma, medulloblastoma, and susceptibility to congenital macrostomia. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~24.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0013300
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007187
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0007187
Submitter: Orphanet
Inheritance Pattern: Unknown
Disease ID:MONDO:0007187
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007187
Submitter: ClinGen
There is one large family with a specific missense mutation (that is otherwise very rare in gnomAD) with a LOD score 2.41 and for which there is extensive functional studies with a Gorlin-like phenotype. The other report is a frameshift variant in a Japanese individual. The Ptch2 mouse knockout model showed related but milder phenotype with no tumors. The evidence that variants in PTCH2 cause a Gorlin-like phenotype (odontogenic cysts, etc) with milder phenotype and lower penetrance than the PTCH1-associated genotype is limited.
Inheritance Pattern: AD
Disease ID:MONDO:0958174
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Dermatologic; Musculoskeletal; Oncologic
Intervention: Oncologic
Rationale: Individuals are at risk for a number of types of malignancies, including basal cell carcinomas and medulloblastoma , as well as (rare) malignant rare keratocysttransformation, and awareness and surveillance may allow early diagnosis and treatment (including with molecular therapies that target the Hedgehog signaling pathway), potentially reducing morbidity and mortality; Avoidance of agents such as radiation therapy is indicated
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PTCH2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003738.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 259 | 11 | 276 | ||
| missense | 554 | 38 | 3 | 595 | ||
| nonsense | 14 | 14 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 40 | 42 | |||
| splice donor/acceptor (+/-2bp) | 21 | 21 | ||||
| Total | 0 | 2 | 635 | 297 | 14 | 948 |
Highest pathogenic variant AF is 0.0000034204406
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003729.3 | 22 | MANE Select | |
| Ensembl | ENSP00000361266.3 | 22 | MANE Select | |
| RefSeq | NP_001159764.1 | 23 | Standard | |
| Ensembl | ENSP00000413169.1 | 5 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ptch2 | Danio rerio | Structure: retinal ganglion cell Quality: mislocalised abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Basal cell carcinoma - Homo sapiens (human)
- Pathways in cancer - Homo sapiens (human)
- Hedgehog signaling pathway - Homo sapiens (human)
- HH-Core
- Hedgehog ,on, state
Biological Process
- cell fate determination
- smoothened signaling pathway
- epidermal cell fate specification
- hair cycle
- skin development
Molecular Function
- smoothened binding
- hedgehog receptor activity
- hedgehog family protein binding
Cellular Component
- plasma membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000372192
- Coding exons
- 22
- Length
- 23220
- Individuals with no LoFs
- 125478
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 269
- Defined
- 125748
- p
- 0.00107
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.785 | 638 | 696 | 0.916 | 0.0000445 | 7665 |
| Missense (PolyPhen) | 166 | 195.86 | 0.84756 | 2196 | ||
| Synonymous | 0.0356 | 304 | 305 | 0.997 | 0.0000198 | 2642 |
| Loss of Function | 2.43 | 33 | 51.9 | 0.635 | 0.00000238 | 561 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00037 | 0.00037 | rare |
| Latino/Admixed American | 0.00096 | 0.00095 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.0038 | 0.0038 | notable |
| Finnish | 0.00023 | 0.00023 | rare |
| European (Non-Finnish) | 0.0011 | 0.0011 | notable |
| South Asian | 0.00065 | 0.00065 | rare |
| Other | 0.00099 | 0.00098 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May have a role in epidermal development. May act as a receptor for Sonic hedgehog (SHH).;
- Disease
- DISEASE: Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269|PubMed:9931336}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Basal cell carcinoma (BCC) [MIM:605462]: A common malignant skin neoplasm that typically appears on hair-bearing skin, most commonly on sun-exposed areas. BCC is slow growing and rarely metastasizes, but has potentialities for local invasion and destruction. It usually develops as a flat, firm, pale area that is small, raised, pink or red, translucent, shiny, and waxy, and the area may bleed following minor injury. Tumor size can vary from a few millimeters to several centimeters in diameter. {ECO:0000269|PubMed:9931336}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.198
Intolerance Scores
- LoFtool
- 0.0291
- RVIS EVS
- -1.52
- RVIS percentile EVS
- 3.47
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.961
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |